This is a major attempt to discredit a very reputable bio venture management team that has taken over AXDX... there is absolutely nothing to the research provided by Citron Research... they have no biotechnology expertise to draw from... the recent SEC correspondence DID NOT shine any new light on the ID/AST technology underdevelopment... there has been no "exposure of fraud"... the technology works as described... and will be a "game changing" technology that will meet vast acceptance once clinical testing is complete and FDA approval is met...
The shareholder lawsuits but the ambulance chasing law firms... is only part of the SHORT selling strategy...
Despite all of this noise... AXDX continues to get significant government grant funding from NIH... and its collaborative partners include the prestigious Washington University School of Medicine in St. Louis...
This is a development stage biotechnology firm... there are little if any revenues... it is well capitalized... and well managed... the technology continues to demonstrate significant reduction in time of identification of multi-drug resistant bacteria... the technology has just received ISA 13485:2003 certifications on its initial installation... and continued expansion of its partner utilization network is occurring at present to gather more testing feedback on the device and technologies applications...
You might very well utilize this very well coordinated SHORT SCARE to find a great entry point for a company that will see PPS between $45 to $70 by mid to late 2016... when the product (which is a razor / razor blade product model)... is fully being marketed with a potential market of every hospital and micro/molecular laboratory in North America... then Europe... then Asia... then everywhere else...
GO AXDX!!!
Recent AXDX News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2024 08:10:34 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/12/2024 09:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 09:30:56 PM
- Accelerate Diagnostics Reports Second Quarter 2024 Financial Results • PR Newswire (US) • 08/08/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:02:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:01:29 PM
- Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical Trial • PR Newswire (US) • 08/08/2024 08:00:00 PM
- Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results • PR Newswire (US) • 08/08/2024 03:09:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 09:16:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 09:06:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 08:25:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 08:15:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:10:14 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/23/2024 11:17:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 11:03:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 09:25:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:06:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:06:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:04:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:03:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:03:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:02:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:00:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 10:59:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 10:57:28 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM